Rina Kansal Selected Research

Therapeutics

1/2011

Good clinical response in a rare aggressive hematopoietic neoplasm: plasmacytoid dendritic cell leukemia with no cutaneous lesions responding to 4 donor lymphocyte infusions following transplant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rina Kansal Research Topics

Disease

4	Neoplasms (Cancer) 07/2018 - 01/2011
2	Lymphoma (Lymphomas) 11/2012 - 02/2005
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2016
1	Extranodal NK-T-Cell Lymphoma 11/2012
1	T-Cell Lymphoma (Lymphoma, T Cell) 11/2012
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2012
1	Trisomy (Trisomies) 02/2005
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2005
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2004

Drug/Important Bio-Agent (IBA)

2	Anaplastic Lymphoma KinaseIBA 11/2012 - 02/2005
1	ParaffinIBA 07/2018
1	Formaldehyde (Formol)FDA Link 07/2018
1	A-Form DNA (A-DNA)IBA 02/2016
1	RNA (Ribonucleic Acid)IBA 11/2012
1	Granzymes (Granzyme)IBA 11/2012
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 04/2004
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 04/2004

Therapy/Procedure

2	Precision Medicine 03/2016 - 08/2015
1	Breast Implants (Breast Implant) 11/2012
1	Therapeutics 01/2011
1	Homologous Transplantation 01/2011